DE68903059T2 - Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten. - Google Patents

Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.

Info

Publication number
DE68903059T2
DE68903059T2 DE8989401861T DE68903059T DE68903059T2 DE 68903059 T2 DE68903059 T2 DE 68903059T2 DE 8989401861 T DE8989401861 T DE 8989401861T DE 68903059 T DE68903059 T DE 68903059T DE 68903059 T2 DE68903059 T2 DE 68903059T2
Authority
DE
Germany
Prior art keywords
formula
carboxymethyl
pyrrol
carboxy
pentanedioic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989401861T
Other languages
German (de)
English (en)
Other versions
DE68903059D1 (de
Inventor
Jacqueline Bonnet
Yannis Tsouderos
Michel Wierzbicki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of DE68903059D1 publication Critical patent/DE68903059D1/de
Publication of DE68903059T2 publication Critical patent/DE68903059T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
DE8989401861T 1988-06-29 1989-06-29 Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten. Expired - Fee Related DE68903059T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808729A FR2633619B1 (fr) 1988-06-29 1988-06-29 Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant

Publications (2)

Publication Number Publication Date
DE68903059D1 DE68903059D1 (de) 1992-11-05
DE68903059T2 true DE68903059T2 (de) 1993-04-29

Family

ID=9367847

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989401861T Expired - Fee Related DE68903059T2 (de) 1988-06-29 1989-06-29 Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.

Country Status (16)

Country Link
US (1) US4939164A (cg-RX-API-DMAC7.html)
EP (1) EP0349432B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0248567A (cg-RX-API-DMAC7.html)
AT (1) ATE81118T1 (cg-RX-API-DMAC7.html)
AU (1) AU613297B2 (cg-RX-API-DMAC7.html)
CA (1) CA1312333C (cg-RX-API-DMAC7.html)
DE (1) DE68903059T2 (cg-RX-API-DMAC7.html)
DK (1) DK325289A (cg-RX-API-DMAC7.html)
ES (1) ES2044170T3 (cg-RX-API-DMAC7.html)
FR (1) FR2633619B1 (cg-RX-API-DMAC7.html)
GR (1) GR3006674T3 (cg-RX-API-DMAC7.html)
IE (1) IE64112B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ229760A (cg-RX-API-DMAC7.html)
OA (1) OA09121A (cg-RX-API-DMAC7.html)
PT (1) PT91006B (cg-RX-API-DMAC7.html)
ZA (1) ZA894945B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
PT1534305E (pt) * 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt) * 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20080167513A1 (en) * 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
DK1768748T4 (da) 2004-06-25 2019-06-11 Mokwalo Spf S A Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
US7875627B2 (en) * 2004-12-07 2011-01-25 Abbott Laboratories Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
WO2016058753A1 (en) 2014-10-14 2016-04-21 Unilever N.V. Device for spraying an enclosure triggered by inclination of a rotatable lid
US10183308B2 (en) 2014-10-14 2019-01-22 Conopco, Inc. Spraying device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954384A (en) * 1960-09-27 Method for preparing kainic acid and its
DE3127275A1 (de) * 1980-12-11 1983-01-27 Leskovar, Peter, Dr.-Ing., 8000 München "harnsteinaufloesende mittel"

Also Published As

Publication number Publication date
IE64112B1 (en) 1995-07-12
ATE81118T1 (de) 1992-10-15
FR2633619B1 (fr) 1991-02-08
CA1312333C (fr) 1993-01-05
JPH0248567A (ja) 1990-02-19
PT91006A (pt) 1989-12-29
GR3006674T3 (cg-RX-API-DMAC7.html) 1993-06-30
IE892094L (en) 1989-12-29
AU3709289A (en) 1990-01-04
PT91006B (pt) 1994-11-30
NZ229760A (en) 1991-06-25
DK325289D0 (da) 1989-06-29
JPH0587064B2 (cg-RX-API-DMAC7.html) 1993-12-15
ES2044170T3 (es) 1994-01-01
ZA894945B (en) 1990-03-28
EP0349432A1 (fr) 1990-01-03
FR2633619A1 (fr) 1990-01-05
DK325289A (da) 1989-12-30
US4939164A (en) 1990-07-03
OA09121A (fr) 1991-10-31
DE68903059D1 (de) 1992-11-05
AU613297B2 (en) 1991-07-25
EP0349432B1 (fr) 1992-09-30

Similar Documents

Publication Publication Date Title
DE69005950T2 (de) Zweiwertige Metallsalze von 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophensäure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
EP0044801B1 (de) Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel
DE69409969T2 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
DE3019350C2 (cg-RX-API-DMAC7.html)
DE2557497C2 (de) Tryptophanderivate und therapeutische Zubereitung
EP0472501B1 (de) Codeinsalz einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und pharmazeutische Präparate
DE2360096C2 (de) 2-Aminomethylen-1-indanon, Verfahren zu dessen Herstellung und dasselbe enthaltende pharmazeutische Mittel
AU613297B2 (en) Strontium salt
DE1940566C3 (de) 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE1932389B2 (de) Neue 2-Naphthyl-2-methyläthanole und deren Acetate, sie enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE2729414A1 (de) Thiazolidincarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2236876C3 (de) N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE2148986C3 (de) Salze der Chondroitinschwefelsäure mit Carboxymethyl-trhnethylammoniumhydroxid, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1493618A1 (de) Cumarinderivate und ein Verfahren zu ihrer Herstellung
DE2919553A1 (de) Tetrahydroisochinolinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel
DE2244737B2 (de) H-o-ChlorphenyD-2-tert-butylaminoäthanol, Verfahren zu dessen Herstellung und Arzneimittel auf dessen Basis
DE2858813C2 (cg-RX-API-DMAC7.html)
DE2107657C3 (de) Arzneimittel zur Behandlung der durch Eisenmangelerscheinungen und Verfahren zur Herstellung des Natriumsalzes von o-Carboxybenzoylferrocens
DE2635293A1 (de) Salzgemisch, insbesondere leicht assimilierbares arzneimittelgemisch mit erhoehter loeslichkeit, enthaltend kalziumsalze und/oder magnesiumsalze
DE2839311C2 (de) Pharmazeutisches Präparat gegen Geschwüre
DE2357320C3 (de) 3-Metnyl-8-methoxy-(3H)-l,2,5.6tetrahydropyrazino- [1,23-ab] - ß -carbolin, seine Salze sowie ein Verfahren zu deren Herstellung und Arzneimittel
AT226705B (de) Verfahren zur Herstellung des neuen N, N-Diphenylisonikotinamids
CH645351A5 (de) O- und m-methylthiophenylaethylamin, verfahren zu ihrer herstellung und pharmazeutische zubereitungen.
CH631175A5 (en) Processes for preparing a novel alkaloid of the vincamine type and salts thereof.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee